Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Simon Benito Insider Profile
32 Followers
Simon Benito, Director at Durect, holds 10.02K shares in Inovio Pharmaceuticals (Ticker: INO), holds 105.00K shares in Durect (Ticker: DRRX).
Profitable Transactions
4 out of 6 Profitable Transactions
Average Return
+7.50%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:May 20, 2020 - May 20, 2021
Return:+54.80%
The most profitable trade made by Simon Benito
Simon Benito's Trading History
Durect
Dec 09, 2021
Director
Informative Buy
20.20K
$94.81K
Inovio Pharmaceuticals
May 16, 2024
Director
Uninformative Buy
28.31K
$39.80K
List of latest transactions for each holding click on a transaction to see Simon Benito's performance on stock
You May Also Like
Simon Benito insider profile FAQ
What is the percentage of profitable transactions made by Simon Benito?
The percentage of profitable transactions made by Simon Benito is 67%.
What is the average return per transaction made by Simon Benito?
The average return per transaction made by Simon Benito is 7.50%.
What stocks does Simon Benito hold?
Simon Benito holds: DRRX, INO stocks.
What was Simon Benito’s latest transaction?
Simon Benito latest transaction was an Uninformative Buy of $28.31K.
What was Simon Benito's most profitable transaction?
Simon Benito’s most profitable transaction was an Informative Sell of INO stock on May 20, 2020. The return on the trade was 54.80%.
What is Simon Benito's role in Durect?
Simon Benito's role in Durect is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.